Cargando…
Results of a Five-Year Experience in First Trimester Preeclampsia Screening
Background and Objectives: The study aimed to evaluate the ability defining the risk of developing preeclampsia by a screening test carried out in the first trimester (between 11 + 0 and 13 + 6 weeks of gestational age), in order to identify high-risk women requiring more intensive health surveillan...
Autores principales: | Capriglione, Stella, Gulino, Ferdinando Antonio, Latella, Silvia, De Felice, Giovanna, Filippini, Maurizio, Farinelli, Miriam, Martire, Francesco Giuseppe, Viora, Elsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369645/ https://www.ncbi.nlm.nih.gov/pubmed/35956169 http://dx.doi.org/10.3390/jcm11154555 |
Ejemplares similares
-
Anti-Mullerian Hormone (AMH) and adenomyosis: Mini-review of literature of the last 5 years
por: Gulino, Ferdinando Antonio, et al.
Publicado: (2022) -
Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year
por: Lourenço, Inês, et al.
Publicado: (2020) -
Integrating Combined First Trimester Screening for Preeclampsia into Routine Ultrasound Examination
por: Trottmann, Fabienne, et al.
Publicado: (2022) -
First-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety
por: Silang, Katherine, et al.
Publicado: (2023) -
Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening
por: Moungmaithong, Sakita, et al.
Publicado: (2023)